Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Goal disturbance and emotional symptoms in patients with cancer.

Journal of behavioral medicine·2026
Same author

Effectiveness of the Participatory Approach on Return-to-Work of Sick-Listed Workers: A Systematic Review and Meta-analysis.

Journal of occupational rehabilitation·2026
Same author

Co-traveling of smoking in people with remitted, recurrent and repeated depression.

Journal of affective disorders·2026
Same author

Adrift in life: A longitudinal qualitative study into the lived experience of persistent suicidality.

Social science & medicine (1982)·2026
Same author

Psychosocial factors and the risk of cancer: An individual-participant data meta-analysis.

Cancer·2026
Same author

Identifying subgroups of frequent emergency department users: a latent class analysis with linked healthcare utilisation, cost and mortality outcomes in the UK.

BMJ public health·2026

Related Experiment Video

Updated: May 16, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Enhanced care for depression.

Aartjan T F Beekman1, Christina van der Feltz-Cornelis, Harm W J van Marwijk

  • 1VUmc University Medical Center, Amsterdam, the Netherlands. a.beekman@ggzingeest.nl

Current Opinion in Psychiatry
|December 1, 2012
PubMed
Summary

Enhanced depression care, particularly collaborative care, shows modest benefits for symptoms and function. This approach is cost-effective and adaptable globally, especially for severe depression cases.

Related Experiment Videos

Last Updated: May 16, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Area of Science:

  • Mental Health Research
  • Health Services Research
  • Comparative Effectiveness Research

Background:

  • Depression care enhancement is crucial for improving patient outcomes.
  • Existing evidence on enhanced depression care requires synthesis across diverse populations and settings.

Purpose of the Study:

  • To review recent evidence on enhanced depression care.
  • To focus on symptomatic, functional, and economic outcomes.
  • To examine effects across different countries, ethnic groups, and settings.

Main Methods:

  • Systematic review of recent trials and evidence.
  • Analysis of symptomatic, functional, and economic outcomes.
  • Cross-national and cross-cultural comparative analysis.

Main Results:

  • Collaborative care is the most studied method for enhancing depression care.
  • Collaborative care demonstrates small but significant improvements over usual care.
  • Effects are more pronounced in patients with complex or severe depression.
  • Collaborative care is cost-effective and adaptable to various healthcare systems and cultures.

Conclusions:

  • Collaborative care shows good value and global applicability.
  • Future focus may shift to severe, complex, or recurrent depression.
  • Further research on work-related functioning and economic productivity is recommended.